NCT04589364View on ClinicalTrials.gov

Study of Abobotulinum Toxin Versus Neubotulinum Toxin Injection For Hemifacial Spasm in Thai Patients

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

August 1, 2026

Conditions
Hemifacial Spasm
Interventions
DRUG

Injection botulinum toxin A ( Dysport 100 unit or Neuronox 33.33 unit)

injection of toxin on facial muscle

Trial Locations (4)

10400

Rajavithi Hospital, Bangkok

34000

Sappasitthiprasong Hospital, Ubon Ratchathani

52000

Lampang Hospital, Lampang

84000

Surat Thani hospital, Surat Thani

All Listed Sponsors
lead

Department of Medical Services Ministry of Public Health of Thailand

OTHER_GOV